top of page

CAREER PROGRESSION AWARD

Submission deadline same as Abstracts

The Career progression Award is presented to early- to mid-career researchers (those who are 3-10 years after obtaining their PhD). The award recognises scientific excellence and achievements within the gene and cell therapy sector, and those who are judged to have potential to be future leaders in their fields. The awardee presents a plenary lecture at the ESGCT Annual Congress.


 Children volunteering

Eligibility Criteria

  • Nominees must be members of the ESGCT

  • All young investigators from PhD + 3 through to 9 years post doc are eligible (this can include post doc position as well as junior PI's)

  • Extension of this period may be allowed in case of eligible career breaks: Maternity or paternity leave (1 year per child born after the PhD award), leave taken for long-term illness, national service, leave taken for unavoidable statutory reasons (e.g. clinical qualification). The cumulative eligibility period should anyhow not surpass 12 years following the award of the first PhD unless the boards agree they are the best candidate for the award

  • For medical doctors, date of the clinical speciality completion is the time reference for calculation of the eligibility time-window. For MD, PhD, date of the PhD award takes precedence in the calculation of the eligibility time-window

Nomination and selection process

Applicants must be nominated by two or more Members of the Society. These nomination should be sent to office@esgct.eu in writing no later than 20 June. Nomination letters should provide an overview of the candidate’s contributions to the field of gene therapy.


Nominations materials include:

  • Two or more nomination letters from Members of ESGCT (500 words or less)

  • Curriculum Vitae and Bibliography of nominee

  • PDF’s of the applicants two best papers

All nominations will be reviewed by the ESCGT Awards Selection Committee.

TOTAL AWARDS VALUE: €1000 (1 x €1000, and complimentary registration to the next annual congress)

Comments


bottom of page